FindTrial
Sign In

Correlation between dynamic changes of peripheral blood T lymphocyte subsets and clinical outcomes in patients with malignant tumor complicated with COVID-19

Correlation between dynamic changes of peripheral blood T lymphocyte subsets and clinical outcomes in patients with malignant tumor complicated with COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059741
Enrollment
Unknown
Registered
2022-05-10
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor complicated with COVID-19

Interventions

None listed

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for confirmed cases of the Novel Coronavirus Pneumonia Diagnosis and Treatment Protocol (Trial ninth Edition); 2. Diagnosed patients with malignant tumors.

Exclusion criteria

Exclusion criteria: 1. Lack of tumor type; 2. The patient was transferred after admission, and the hospitalization time was less than 24h.

Design outcomes

Primary

MeasureTime frame
T lymphocyte subsets;—

Countries

China

Contacts

Public ContactKun Han

Shanghai Jiaotong University Affiliated Sixth People's Hospital

doctor_hankun@163.com+86 18930172973

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026